WELL’s CRH Medical Continues Digitization Progress with Strategic Investment in Graphium Health

WELL Health Technologies Corp. a practitioner-focused digital health company that is positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to provide key business updates to its wholly owned subsidiary CRH Medical Corp. (“CRH”).

CRH Medical, a subsidiary of WELL Health Technologies, announces a significant milestone in its pursuit of enhancing digitization across the CRH platform with the recent strategic investment in Graphium Health LP (“Graphium”). This investment marks a pivotal moment in CRH’s history as it continues to prioritize technology enablement to deliver performance enhancement and improved patient experiences. In the fourth quarter of 2021, CRH embarked on a journey to transition its RCM service partners, aiming to modernize and optimize its overall RCM performance. This process revealed opportunities for CRH to leverage technologically enabled point solutions, including artificial intelligence (AI), process automation, data analytics, and patient-focused data science. Through these innovations, CRH is well on its way to transforming its RCM capabilities and disseminating these advancements throughout the broader WELL Health Technologies ecosystem.